Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human HLA-G Protein, N-GST

Catalog #:   YHD25801 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P17693
Protein length: Met29-His117
Overview

Catalog No.

YHD25801

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Met29-His117

Predicted molecular weight

37.24 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P17693

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

HLAG, HLA-G, sHLA-G, HLA G antigen, MHC class I antigen G, HLA-6.0, HLA class I histocompatibility antigen, alpha chain G

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human HLA-G
References

Regulatory effects of lncRNA PVT1 on transcriptome in human breast cancer MDA-MB-231 cell line determined by in silico analyses., PMID:40464801

Cervical EVT isolation for non-invasive fetal HLA typing in early pregnancy is limited by purity and maternal cell contamination; a methodological comparison., PMID:40416984

The Impact of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen-E, Human Leukocyte Antigen-G Polymorphisms on Innate Immunity and COVID-19 Severity., PMID:40391199

Immune dysregulation in endometrial tuberculosis: elevated HLA-G and IL-1Ra as key modulators., PMID:40375897

Human Cytomegalovirus Antigen Presentation by HLA-G in Infected Cells., PMID:40347012

PARP inhibition elicits NK cell-associated immune evasion via potentiating HLA-G expression in tumor., PMID:40328191

Exosome biomarkers in breast cancer: Systematic review and meta-analysis., PMID:40311726

Mechanism of microRNA-152 Regulating Decidual Natural Killer Cell Viability and Affecting Trophoblast Cell Invasiveness via the HLA-G/KIR2DL4 Axis., PMID:40309956

First trimester extravillous trophoblast secretes HLA class I molecules via small extracellular vesicles., PMID:40300266

Immune evasion strategies in AFP-producing gastric carcinoma: characterized by HLA-G expression and HLA class I deficiency., PMID:40278871

Different behavior of NK cells isolated from healthy women and women with recurrent spontaneous abortion after treatment with human amniotic epithelial cells., PMID:40276927

Human leukocyte antigen-G in hepatocellular carcinoma driven by chronic viral hepatitis or steatotic liver disease., PMID:40246934

Homozygous AA Genotype of IL-17A and 14-bp Insertion Polymorphism in HLA-G 3'UTR Are Associated with Increased Risk of Gestational Diabetes Mellitus., PMID:40238306

The multifaceted roles of the transcriptional coactivator TAZ in extravillous trophoblast development of the human placenta., PMID:40228123

Increase of VEGF and Fibronectin expression and ultrastructural alterations of intercellular junctions in a swab negative patient after SARS-COV-2 infection., PMID:40114185

The TEA domain transcription factors TEAD1 and TEAD3 and WNT signaling determine HLA-G expression in human extravillous trophoblasts., PMID:40096597

Determining Sex-Specific Gene Expression Differences in Human Chorion Trophoblast Cells., PMID:40076861

In vitro differentiation of macaque extravillous trophoblasts in a low oxygen environment., PMID:40024139

Colony-stimulating factor 3 and its receptor promote leukocyte immunoglobulin-like receptor B2 expression and ligands in gastric cancer., PMID:39958563

Decoding Cytokine Dynamics: Wharton's Jelly Stromal Cells and Chondro-Differentiates in PHA-Stimulated Co-Culture., PMID:39936966

A novel aptamer-based probe for the identification and enrichment of trophoblast cells., PMID:39903971

Cancer and Secretomes: HLA-G and Cancer Puzzle., PMID:39841384

Enhanced effect of the immunosuppressive soluble HLA-G2 homodimer by site-specific PEGylation., PMID:39833185

Influence of HLA-G 3' Untranslated Region Haplotypes and SNP +3422 Gene Variants as Host Genetic Factors on the Outcomes of SARS-CoV-2 Infection During Acute and Post-Acute Phases in a German Cohort., PMID:39711218

Immune-checkpoint HLA-G gene polymorphisms, 3'-UTR types and their association with hepatocellular carcinoma and treatment response in Indian population., PMID:39703498

Associations of HLA-G 3'UTR polymorphisms and increased HLA-G expression with gastric cancer susceptibility and prognosis., PMID:39693801

Association of HLA-G 3'-UTR Haplotypes With Recurrent Spontaneous Abortion in Women From Northwest Iran., PMID:39664015

Characterisation of the Novel HLA-G*01:06:01:02 Allele in a Tribal Individual From Western Maharashtra, India., PMID:39663873

HLA-G liver expression in chronically HIV/hepatitis C-coinfected individuals., PMID:39631457

The 14-bp insertion/deletion as a promising gene polymorphism to understand cancer risk: Evidence from a systematic review and comprehensive meta-analysis., PMID:39605806

Ralationship between polymorphisms and diplotypes of HLA-G 3'UTR and fetuses with abnormal chromosomes or unexplained pregnancy loss (UPL)., PMID:39551809

HLA-G high-expressor 3'UTR markers are linked to gastric cancer development and survival., PMID:39549048

HLA-G can be transfered via trogocytosis from leukemic cells to T cells in chronic lymphocytic leukemia., PMID:39541623

Immunomodulatory properties of extracellular vesicles isolated from bone marrow of patients with neuroblastoma: role of PD-L1 and HLA-G., PMID:39512342

Association Study of rs1632947, rs1233334, and rs371194629 Polymorphisms in Human Leukocyte Antigen G Gene Expression and soluble Human Leukocyte Antigen G with Lupus., PMID:39503744

Impact of Vitamin D deficiency on immunological and metabolic responses in women with recurrent pregnancy loss: focus on VDBP/HLA-G1/CTLA-4/ENTPD1/adenosine-fetal-maternal conflict crosstalk., PMID:39472874

HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevance., PMID:39469714

Eight Novel HLA Class I Alleles Identified in Unrelated Haematopoietic Cell Donors and Recipients., PMID:39465562

Identification of the Novel Non-classical HLA-G*01:24:02 Allele by Next-Generation Sequencing., PMID:39462175

HLA-G - evolvement from a trophoblast specific marker to a checkpoint molecule in cancer, a narrative review about the specific role in breast- and gynecological cancer., PMID:39432974

The Immune Modulation HLA-G*01:01:01 Full Allele Is Associated with Gastric Adenocarcinoma Development., PMID:39408976

Effect modification between HLA-F and CD56 markers reveals differences in survival for triple-negative breast cancer patients., PMID:39405828

HLA-G neo-expression modifies genetic programs governing tumor cell lines., PMID:39358558

Circulating Vesicular-bound HLA-G as Noninvasive Predictive Biomarker of CLAD After Lung Transplantation., PMID:39294868

Accurate multi-population imputation of MICA, MICB, HLA-E, HLA-F and HLA-G alleles from genome SNP data., PMID:39283896

Human Leukocyte Antigen-G Gene Polymorphism in Peninsular Malaysia: A Preliminary Report., PMID:39279581

Association Study of 3-untranslated region Haplotype of Human leukocyte antigen-G Gene with Lupus., PMID:39250772

A chimeric anti-vascularization immunomodulator prevents high-risk corneal transplantation rejection via ex vivo gene therapy., PMID:39245940

Targeting Dual Immune Checkpoints PD-L1 and HLA-G by Trispecific T Cell Engager for Treating Heterogeneous Lung Cancer., PMID:39234811

PGRMC2 and HLA-G regulate immune homeostasis in a microphysiological model of human maternal-fetal membrane interface., PMID:39179795

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human HLA-G Protein, N-GST [YHD25801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only